Exacerbation of experimental autoimmune encephalomyelitis by passive transfer of IgG antibodies from a multiple sclerosis patient responsive to immunoadsorption

Journal of Neuroimmunology

Volumn 262, Issue 1-2, 2013, Pages 19-26

  Pedotti, Rosetta ^a   Musio, Silvia ^a   Scabeni, Stefano ^a   Farina, Cinthia ^a,b   Poliani, Pietro Luigi ^c   Colombo, Emanuela ^b   Costanza, Massimo ^a   Berzi, Angela ^a   Castellucci, Fabrizio ^d   Ciusani, Emilio ^a   Confalonieri, Paolo ^a   Hemmer, Bernhard ^e   Mantegazza, Renato ^a   Antozzi, Carlo ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

^d BOCCONI UNIVERSITY   (Italy)

^e HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Antibodies; Demyelination; Experimental autoimmune encephalomyelitis; Immunoadsorption; Multiple sclerosis; Plasma exchange

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; METHYLPREDNISOLONE; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PROTEIN A;

ADULT; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; AREA UNDER THE CURVE; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; DEMYELINATION; DISEASE EXACERBATION; DRUG MEGADOSE; FEMALE; GRAY MATTER; HUMAN; IMMUNOADSORPTION; IMMUNOREACTIVITY; IN VIVO STUDY; MOLECULAR PATHOLOGY; MOUSE; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; NONHUMAN; OLIGODENDROGLIA; PASSIVE IMMUNIZATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN PURIFICATION; WHITE MATTER;

ANTIBODIES; DEMYELINATION; EAE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IMMUNOADSORPTION; LNCS; LYMPH NODE CELLS; MS; MULTIPLE SCLEROSIS; MYELIN PROTEOLIPID PROTEIN; PBS; PHOSPHATE BUFFER SALINE; PLASMA EXCHANGE; PLP; T HELPER; TH; TPE;

ADULT; ANIMALS; CENTRAL NERVOUS SYSTEM; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN G; IMMUNOSORBENT TECHNIQUES; IMMUNOSORBENTS; MICE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PLASMA EXCHANGE;

EID: 84884165618     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2013.05.010     Document Type: Article

References (32)

1. Antozzi C., Granata T., Aurisano N., Zardini G., Confalonieri P., Airaghi G., Mantegazza R., Spreafico R. Long-term selective IgG immuno-adsorption improves Rasmussen's encephalitis. Neurology 1998, 51(1):302-305.
2. Antozzi C., Frassoni C., Vincent A., Regondi M.C., Andreetta F., Bernasconi P., Ciano C., Chang T., Cornelio F., Spreafico R., Mantegazza R. Sequential antibodies to potassium channels and glutamic acid decarboxylase in neuromyotonia. Neurology 2005, 64(7):1290-1293.
3. Bar-Or A., Fawaz L., Fan B., Darlington P.J., Rieger A., Ghorayeb C., Calabresi P.A., Waubant E., Hauser S.L., Zhang J., Smith C.H. Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?. Ann. Neurol. 2010, 67(4):452-461.
4. Bradl M., Misu T., Takahashi T., Watanabe M., Mader S., Reindl M., Adzemovic M., Bauer J., Berger T., Fujihara K., Itoyama Y., Lassmann H. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann. Neurol. 2009, 66(5):630-643.
5. Bruck W., Bitsch A., Kolenda H., Bruck Y., Stiefel M., Lassmann H. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann. Neurol. 1997, 42(5):783-793.
6. Fukunaga H., Engel A.G., Lang B., Newsom-Davis J., Vincent A. Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones. Proc. Natl. Acad. Sci. U. S. A. 1983, 80(24):7636-7640.
7. Genain C.P., Nguyen M.H., Letvin N.L., Pearl R., Davis R.L., Adelman M., Lees M.B., Linington C., Hauser S.L. Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. J. Clin. Invest. 1995, 96(6):2966-2974.
8. Genain C.P., Cannella B., Hauser S.L., Raine C.S. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat. Med. 1999, 5(2):170-175.
9. Goverman J. Autoimmune T cell responses in the central nervous system. Nat. Rev. Immunol. 2009, 9(6):393-407.
10. Hauser S.L., Waubant E., Arnold D.L., Vollmer T., Antel J., Fox R.J., Bar-Or A., Panzara M., Sarkar N., Agarwal S., Langer-Gould A., Smith C.H. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N. Engl. J. Med. 2008, 358(7):676-688.
11. Kanter J.L., Narayana S., Ho P.P., Catz I., Warren K.G., Sobel R.A., Steinman L., Robinson W.H. Lipid microarrays identify key mediators of autoimmune brain inflammation. Nat. Med. 2006, 12(1):138-143.
12. Keegan M., Konig F., McClelland R., Bruck W., Morales Y., Bitsch A., Panitch H., Lassmann H., Weinshenker B., Rodriguez M., Parisi J., Lucchinetti C.F. Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange. Lancet 2005, 366(9485):579-582.
13. Kinoshita M., Nakatsuji Y., Kimura T., Moriya M., Takata K., Okuno T., Kumanogoh A., Kajiyama K., Yoshikawa H., Sakoda S. Neuromyelitis optica: passive transfer to rats by human immunoglobulin. Biochem. Biophys. Res. Commun. 2009, 386(4):623-627.
14. Lalive P.H., Menge T., Delarasse C., Della Gaspera B., Pham-Dinh D., Villoslada P., von Budingen H.C., Genain C.P. Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(7):2280-2285.
15. Linington C., Bradl M., Lassmann H., Brunner C., Vass K. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am. J. Pathol. 1988, 130(3):443-454.
16. Llufriu S., Castillo J., Blanco Y., Ramio-Torrenta L., Rio J., Valles M., Lozano M., Castella M.D., Calabia J., Horga A., Graus F., Montalban X., Saiz A. Plasma exchange for acute attacks of CNS demyelination: predictors of improvement at 6months. Neurology 2009, 73(12):949-953.
17. Lucchinetti C., Bruck W., Parisi J., Scheithauer B., Rodriguez M., Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 2000, 47(6):707-717.
18. Lucchinetti C., Altintas A., Wegner C., Menk S., Lassmann H., Bitsch A., Parisi J., Bruck W. Magnetic resonance imaging correlates of multiple sclerosis pathologic subtypes. Ann. Neurol. 2003, 54(Suppl. 7):S37.
19. Magana S.M., Keegan B.M., Weinshenker B.G., Erickson B.J., Pittock S.J., Lennon V.A., Rodriguez M., Thomsen K., Weigand S., Mandrekar J., Linbo L., Lucchinetti C.F. Beneficial plasma exchange response in central nervous system inflammatory demyelination. Arch. Neurol. 2011, 68(7):870-878.
20. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., McFarland H.F., Paty D.W., Polman C.H., Reingold S.C., Sandberg-Wollheim M., Sibley W., Thompson A., van den Noort S., Weinshenker B.Y., Wolinsky J.S. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 2001, 50(1):121-127.
21. McLaughlin K.A., Wucherpfennig K.W. B cells and autoantibodies in the pathogenesis of multiple sclerosis and related inflammatory demyelinating diseases. Adv. Immunol. 2008, 98:121-149.
22. Meinl E., Derfuss T., Krumbholz M., Probstel A.K., Hohlfeld R. Humoral autoimmunity in multiple sclerosis. J. Neurol. Sci. 2011, 306(1-2):180-182.
23. Musio S., Gallo B., Scabeni S., Lapilla M., Poliani P.L., Matarese G., Ohtsu H., Galli S.J., Mantegazza R., Steinman L., Pedotti R. A key regulatory role for histamine in experimental autoimmune encephalomyelitis: disease exacerbation in histidine decarboxylase-deficient mice. J. Immunol. 2006, 176(1):17-26.
24. O'Connor K.C., McLaughlin K.A., De Jager P.L., Chitnis T., Bettelli E., Xu C., Robinson W.H., Cherry S.V., Bar-Or A., Banwell B., Fukaura H., Fukazawa T., Tenembaum S., Wong S.J., Tavakoli N.P., Idrissova Z., Viglietta V., Rostasy K., Pohl D., Dale R.C., Freedman M., Steinman L., Buckle G.J., Kuchroo V.K., Hafler D.A., Wucherpfennig K.W. Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Nat. Med. 2007, 13(2):211-217.
25. Pedotti R., Mitchell D., Wedemeyer J., Karpuj M., Chabas D., Hattab E.M., Tsai M., Galli S.J., Steinman L. An unexpected version of horror autotoxicus: anaphylactic shock to a self-peptide. Nat. Immunol. 2001, 2(3):216-222.
26. Raine C.S., Cannella B., Hauser S.L., Genain C.P. Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation. Ann. Neurol. 1999, 46(2):144-160.
27. Schluesener H.J., Sobel R.A., Linington C., Weiner H.L. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J. Immunol. 1987, 139(12):4016-4021.
28. Sommer C., Weishaupt A., Brinkhoff J., Biko L., Wessig C., Gold R., Toyka K.V. Paraneoplastic stiff-person syndrome: passive transfer to rats by means of IgG antibodies to amphiphysin. Lancet 2005, 365(9468):1406-1411.
29. Toyka K.V., Brachman D.B., Pestronk A., Kao I. Myasthenia gravis: passive transfer from man to mouse. Science 1975, 190(4212):397-399.
30. von Budingen H.C., Hauser S.L., Ouallet J.C., Tanuma N., Menge T., Genain C.P. Frontline: epitope recognition on the myelin/oligodendrocyte glycoprotein differentially influences disease phenotype and antibody effector functions in autoimmune demyelination. Eur. J. Immunol. 2004, 34(8):2072-2083.
31. Weinshenker B.G., O'Brien P.C., Petterson T.M., Noseworthy J.H., Lucchinetti C.F., Dodick D.W., Pineda A.A., Stevens L.N., Rodriguez M. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann. Neurol. 1999, 46(6):878-886.
32. Zhou D., Srivastava R., Nessler S., Grummel V., Sommer N., Bruck W., Hartung H.P., Stadelmann C., Hemmer B. Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(50):19057-19062.